The protein products of these genes (in particular, of GSN, NDUFAF8, KIR3DS1, KRTAP10.1, TBC1D12, RAB4B, and ATPIF1) could be investigated as potential novel biomarkers and therapeutic targets against airway remodeling in EA. This evidence concerns the gene TBC1D12 and Esophageal atresia.